Healthcare services company CVS Health (NYSE: CVS) has updated its 2025 full-year financial guidance and issued forecasts for fiscal 2026.
- The company raised its revenue guidance for fiscal 2025 to at least $400.0 billion from the earlier forecast of $397.3 billion
- The outlook for FY25 adjusted earnings per share has been increased to $6.60-$6.70 from $6.55-$6.65 estimated earlier
- It also reaffirmed its fiscal 2025 cash flow from operations guidance range of $7.5 billion to $8.0 billion
- For fiscal 2026, the management forecasts total revenues of at least $400.0 billion
- It sees FY26 earnings per share in the range of $5.94 to $6.14, and adjusted earnings per share between $7.00 and $7.20
- FY26 operating income is expected to be in the range of $13.26 billion to $13.60 billion, and adjusted operating income in the $15.07-$15.41 billion range
- Cash flow from operations is expected to be at least $10.0 billion in fiscal 2026
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
After a rollercoaster year, is Tesla (TSLA) stock a good bet?
In recent years, Tesla's (NASDAQ: TSLA) stock has often swung between record highs and sharp corrections, reflecting shifts in investor sentiment, broader economic conditions, and changes in its financial performance.
Dollar Tree (DLTR), Dollar General (DG): Discount stores remain key gainers in a value-conscious landscape
Discount retailers Dollar Tree, Inc. (NASDAQ: DLTR) and Dollar General Corporation (NYSE: DG) have seen their stocks gain more than 30% in the past three months. The dollar stores continue
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the
